Regular Insulin (Human) Injectable Suppliers & Bulk Manufacturers

Available Forms: Vials/pens

Available Strengths: U-100 (100 units/mL)

Reference Brands: Humulin R, Novolin R, Admelog R(US); Actrapid, Humulin R, Monotard R(EU)

Category: Diabetes

Regular Insulin (Human) works by mimicking natural insulin to regulate blood glucose levels, reducing hyperglycemia in diabetics. Its benefits include rapid blood sugar control, predictable action, and widespread availability, making it essential for managing both type 1 and type 2 diabetes effectively. Regular Insulin (Human) Injectable is available in Vials/pens and strengths such as U-100 (100 units/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Regular Insulin (Human) Injectable is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Regular Insulin (Human) Injectable can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Regulatory approval for Regular Insulin (Human) in the EU and US ensures safety, efficacy, and quality. In the EU, brands like Actrapid and Humulin R are approved by EMA, including biosimilars that enhance access. In the US, FDA-approved options include Humulin R, Novolin R, and biosimilars such as Admelog R. Both regions require comprehensive dossiers demonstrating biosimilarity, manufacturing standards, and post-marketing surveillance to maintain high-quality standards. For detailed information on regulatory processes, visit PharmaTradz, your trusted source for pharmaceutical dossier support and compliance solutions.